Search

everythinglearnresearchcommunity

for

Search:↓

Metformin lowers prolactin in men with normal hair but not in those with early hair loss.

Prolactin speeds up hair growth and moulting in cashmere goats.

Melatonin implants can change the seasonal prolactin levels and hair growth in adult cashmere goats but not in juveniles, and don't delay spring moult for better fiber harvesting.

Goat reproductive activity and coat growth are affected by light and temperature, with temperature altering prolactin levels and hair growth, but not melatonin or estrus onset.

Melatonin treatment started hair growth in goats and affected their hormone levels.

Neurosteroids affect prolactin levels in sheep differently depending on stress and pregnancy conditions.

Men with early balding often have hormone levels similar to women with polycystic ovary syndrome.

The treatment significantly reduced hair growth and male hormone levels in hirsute women.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Low-dose spironolactone is safe and effective for treating hirsutism.

Cimetidine does not significantly reduce hair growth in hirsutism.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Selecting Angus cattle for earlier puberty lowers prolactin levels but doesn't affect hair growth.

Lower testosterone levels in men may be linked to a higher risk of severe coronary artery disease.

Men with low or no sperm count have lower salivary testosterone levels, and saliva testing can measure their testosterone well.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Men with hair loss have lower SHBG and higher saliva testosterone levels, suggesting increased androgen activity.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

Higher doses of oestradiol implants improve bone density in postmenopausal women.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

High levels of prolactin in the blood can be linked to widespread hair loss.

Hormone imbalances from endocrine diseases can cause various skin conditions that help diagnose and treat these diseases early.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

Type 2 diabetes in youth is increasing, with high treatment failure rates and more severe than Type 1; certain drugs can lower lipid levels effectively with varying side effects, and apples may benefit heart health like statins but with fewer side effects.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.